Suchergebnisse - "Oh, Bora"

PubPharm (39)

1

Clinicogenomic characteristics and synthetic lethal implications of germline homologous recombination-deficient hepatocellular carcinoma

enthalten in: Hepatology (Baltimore, Md.) | 2023

von An, J. | Oh, J. | Oh, B. | +6

CommentIn: Hepatology. 2023 Aug 1;78(2):375-377. - PMID 36626621

2

Integrated prognostic and histogenomic justification of stage-directed therapy for single large hepatocellular carcinoma : a Korean nationwide registry study

enthalten in: Gut | 2022

von An, J. | Kim, H. | Oh, B. | +5

CommentOn: Gut. 2020 Oct;69(10):1893-1895. - PMID 31748202

3

PET-Based Radiogenomics Supports mTOR Pathway Targeting for Hepatocellular Carcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von An, J. | Oh, M. | Kim, S. | +9

4

Comprehensive characterization of viral integrations and genomic aberrations in HBV-infected intrahepatic cholangiocarcinomas

enthalten in: Hepatology (Baltimore, Md.) | 2022

von An, J. | Kim, D. | Oh, B. | +16

5

Comprehensive characterization of viral integrations and genomic aberrations in HBV‐infected intrahepatic cholangiocarcinomas

enthalten in: Hepatology | 2022

von An, J. | Kim, D. | Oh, B. | +16

6

Prognostic Molecular Indices of Resectable Hepatocellular Carcinoma : Implications of S100P for Early Recurrence

enthalten in: Annals of surgical oncology | 2021

von Hwang, H. | An, J. | Kang, H. | +7

7

Prognostic Molecular Indices of Resectable Hepatocellular Carcinoma: Implications of S100P for Early Recurrence

enthalten in: Annals of surgical oncology | 2021

von Hwang, H. | An, J. | Kang, H. | +7

8

Prognostic Molecular Indices of Resectable Hepatocellular Carcinoma: Implications of S100P for Early Recurrence

enthalten in: Annals of surgical oncology | 2021

von Hwang, H. | An, J. | Kang, H. | +7

9

Prognostic Molecular Indices of Resectable Hepatocellular Carcinoma: Implications of S100P for Early Recurrence

enthalten in: Annals of surgical oncology | 2021

von Hwang, H. | An, J. | Kang, H. | +7

10

The HSP90 inhibitor, NVP-AUY922, sensitizes KRAS-mutant non-small cell lung cancer with intrinsic resistance to MEK inhibitor, trametinib

enthalten in: Cancer letters | 2016

von Park, K. | Oh, B. | Lee, M. | +6